Amyloidosis and Fabry Disease

Part I - Amyloidosis

1. Description and Purposes: An Overview2. Neurological Manifestations



3. Dysautonomy

4. Cardiology Manifestations

5. Syncope, Arrhythmia and Cardiac Devices

6. Urological and Kidney manifestations7. Ophthalmological and Dermatological Manifestations



8. Gastrointestinal Symptoms

9. Hematological Associations10. Orthopedic Care



11. Association of Neoplasms

12. Diagnostic tools13. Genetics and Epigenetics



14. Treatment

 

Part II - Fabry Disease

15. Clinical Course: An Overview

16. Neurological Manifestations

17. Cardiology Manifestations

18. Kidney manifestations

19. Ophthalmological and Dermatological Manifestations

20. Gastrointestinal Symptoms

21. Diagnostic tools

22. Genetics

23. Treatment

 

Part III - Amyloidosis and Fabry Disease

24. Pathology and Differential Diagnosis

25. Clinical Research26. The Role of Nursing in Chronic Patient's Care



27. Chronic Pain and Quality of Life

Diane Ávila graduated in Medicine at the UNESA, Brazil (2013). Clinical doctor, cardiologist and researcher. She completed her Master's degree in Cardiovascular Sciences at the Fluminense Federal University (Rio de Janeiro, Brazil, 2016). Currently, she is a coinvestigator in the APOLLO B trial, is a coordinator of the amyloidosis center CHN-DASA and a PhD student in heart failure. Dr. Ávila's research interests include systemic amyloidosis, chronic heart failure, cardiomyopathies, biomarkers, cardiometabolism and COVID-19.

 

Humberto Villacorta Junior graduated in Medicine at the Federal University of Pará, Brazil (1987). He completed his Master's degree in Cardiovascular Sciences at the Fluminense Federal University (Rio de Janeiro, Brazil, 1998) and his PhD in Cardiology at the University of São Paulo (São Paulo, Brazil, 2002). He completed his MBA in Health Management at the Fundação Getúlio Vargas in 2015 (Rio de Janeiro, Brazil). He attended a Preceptorship on Heart Failure at Brigham and Women's Hospital, Harvard Medical School (Boston, USA, 2016) and a Preceptorship Program on Heart Failure at the Hospitals San Carlos, Ramón y Cajal and Puerta de Hierro (Madrid, Spain, 2017). A Fellow of the European Society of Cardiology and of the Brazilian Society of Cardiology. He is a Founding Member of the Heart Failure Department of the Brazilian Society of Cardiology (DEIC). He was the President of the Heart Failure Department, Rio de Janeiro Society of Cardiology (2001-2002 biennium) and is currently the Scientific Director since 2016. He is the Editor of the Biomarker Section in the recently launched "Arquivos Brasileiros de Cardiologia, Heart Failure and Cardiomyopathies". He is a member of the Editorial Board of the journal Arquivos Brasileiros de Cardiologia since 2014 and a member of the group responsible for the Brazilian Heart Failure Guidelines (2005, 2012, 2018, and 2021). Prof. Villacorta has been the leader in the